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Some Clinical Fallout 
Oxygen Consumption 
of the Heart: Newer Concepts 
of Its Multifactoral Determination 
by E. H. Sonnenblick, J. Ross, Jr., E. Braunwald (1) 
Revie~ 
My interest in the control of  myocardial oxygen consump- 
tion (MVO 2) began in 1955, when as a postdoctoral feUow, 
ABSTRACT 
The factors that control the consumption ofoxygen and utili- 
zation of energy by the heart have been of interest o cardio- 
vascular physiologists and clinicians for many years. The 
d,'terminants ofmyocardial oxygen consumption (M#O~ have 
~,vmranted this careful consideration since, in the presence of 
sh'ady state conditions and ~oith the obligatory aerobic nature of 
myocardial metabolism, MVO 2 serves as a measure of the total 
energy utilization oft  he heart. Therefore, since utilization of 
/,igh energy phosphates, vohich constitute the immediate nergy 
source for contraction, is not readily determined directly, advan- 
tage is taken of the close con'elation bet~oeen ergy utilization 
and M#O 2, and the latter is measured experimentally. Further, 
under clinical conditions that place a restraint on coronary blood 
flo.w and, hence, on the availability of oxygen to the myocar- 
dram, factors that alter MVO 2 become a primary consideration. 
d major advance in our understanding ofthe determinants of
MVO 2 has come fi'om an appreciation that cardiac muscle is 
subject to the same general princ~les of control and analysis as 
is skeletal muscle. Thus, the same factors that govern the 
conversion of chemical energy into mechanical work in skeletal 
muscle are important considerations in dealing with heart 
muscle. In the present discussion the development ofan integra- 
tive concept of the determination of MVO 2 voill be revie~oed, 
and its relation to our present knovdedge of muscle mechanics 
~will be assessed briefly. Such a synthesis may oiler insight into 
some of the apparent diso'epancies and inconsistencies ~oith 
v:bich the literature on the subject abounds and may provide a 
more rationalj~amework for understanding the dynamic ontrol 
of MVO 2 in both physiologic and patbologic states. 
Originally published in the American Journal of Cardiology, September 
1968. 
From Harvard Medical School, P.-u'tners HealthCare System and Brigham and 
Women's Hospital, Boston, Massachusetts. 
50th .4nniversaw Historical Article 
INTRODUCTION 
In this edition of the Journal, we release the twelfth in a series 
of reviews of influential articles that have been previously 
published in ACC journals, including the American Journal of 
Cardiology (from 1958 to 1982) and JACC (from 1983 to the 
presen0. The publication of these articles is only one aspect of the 
ACC's 50th anniversary commemoration, which highlights 50 
years of leadership in cardiovascular care and education. The 
articles are intended to encourage reflection on the remarkable 
progress made in cardiovascular medicine over time, as well as to 
acknowledge the amazing prescience of some early investigators in 
anticipating and, in many cases, later guiding developments in
their field. 
The working group responsible for selecting these articles and 
asking reviewers to write editorials solicited suggestions from 
the ACC's clinical committees and individual members. 
The group achieved consensus fairly easily, including whom the 
group should ask to prepare the accompanying editorials. We 
initially drew up a list of 14 general areas to cover in this series, 
but later found that there are several major areas of modem 
cardiology, prominently molecular cardiology, in which the truly 
landmark articles have, alas, not yet been published in JACC. 
Therefore, the working roup decided not to categorize by subject, 
but instead, to concentrate on the most important articles. 
The working group, a task force of the Subcommittee for the 
Commemoration f the ACC 50th Anniversary, owes a great 
deal to Ms. May A. Roustom and the efficient and tireless taff 
at Heart House for facilitating this project. We also wish to 
thank all who suggested articles and, most important, the 
authors who prepared reviews for their willingness to contribute 
their time and wisdom. 
Influential Articles in JACC Working Group 
Sharon A. Hunt, M.D., F.A.C.C. 
Rick A. Nishimura, M.D., F.A.C.C. 
H.J.C. Swan, M.D., Ph.D., M.A.C.C. 
Michael J. Wolk, M.D., F.A.C.C. 
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I joined the team led by Stanley J. Sarnoff in the Laboratory 
of Cardiovascular Physiology at the (then) National Heart 
Institute to investigate the hemodynamic determinants of
this critical variable. The importance of M{rO2 had been 
appreciated since the work of Evans and Matsuoko (2) in 
Ernest Starling's laboratory at the beginning of the 20th 
century. These investigators understood that the heart is an 
aerobic organ and cannot (except for very brief periods) 
develop an oxygen debt. However, there had been surpris- 
ingly little research on this important aspect of cardiovas- 
cular physiology for four decades, and we felt that if we 
could "get a handle on" the determinants of M~rO2, we 
would gain important insights into the heart's total meta- 
bolic activity and could then relate this to its contractile 
function. 
Our first task was to develop acanine heart preparation i
which the key hemodynamic parameters (preload, afterload 
and heart rate) could be accurately measured and indepen- 
dently controlled. In the classical heart-lung preparation, 
heart failure is progressive, but we needed to maintain 
normal cardiac function over several hours. This would 
avoid the confounding influence of progressive reductions of 
contractility and of ventricular dilation on the relation 
between cardiac contraction and energetics. Therefore, in 
our "isolated supported heart preparation," we used a sepa- 
rate support dog whose circulation was in series with the 
isolated heart and whose lungs served to oxygenate the 
blood (3). The idea for this preparation had been sparked by 
the technique of controlled cross circulation, which allowed 
open-heart surgery to be performed before the perfection of 
the heart-lung machine. 
These experiments were both complex and cosily; they 
involved the use of a new generation of flow meters that 
provided simultaneous and precise measurement of 
cardiac output and coronary blood flow. Each experi- 
ment took a team of eight investigators, post docs and 
technicians about 18 h, and the manual analysis of 
the records produced by the first eight-channel recorder 
used in cardiovascular physiology took us another week 
or so. 
From this study we learned that at any heart rate, 
intraventricular p essure was the most important determi- 
nant of MVO 2. The area under the left intraventricular 
pressure curve, which we termed the "tension-time index," 
proved to be an even better correlate of MVO2 than the 
peak pressure itself because this area takes account of the 
important effects of heart rate and the relatively modest 
effects of stroke volume (4). Having established the tension- 
time index as a major determinant ofM~rO2, we went on to 
demonstrate hat MVO2, in turn, is the major determinant 
of coronary blood flow (5). Subsequently, other investigators 
devised techniques for calculating ventricular wall tension, 
an even closer correlate of MVO 2 than the tension-time 
index (6). 
Control of Myocardial 
Oxygen Consumption: 
Physiologic and Clinical Considerations 
by E. Braunwald (7) 
ABSTRACT 
The basal oxygen consumption of the heart is small, approxi- 
mately 20percent of that of the contracting organ. Oxygen cost 
of depolarization is approximately 0.5 percent of the tota/ 
oxygen consumed by the normally working heart. There is afar 
ore'eater oxygen cost of"pressure work" as opposed to ~tow work, "' 
and a close relation between the area beneath the left ventricula, 
pressure cm've, that is, the tension-time index, and myocardial 
oxygen consumption. Also, the conh'actile state of the heart, a, 
reflected in the maximal velocity of isotonic shortening, is a 
major determinant of myocardial oxygen consumption. Thus. 
velocity of conlv'action shares the role of important determinant 
of myocardial oxygen consumption with developed tension and 
heart rate. Although the precise costs of activation and mainte- 
nance of the active state of the myocardium have not yet beea~ 
clearly deflated, it is likely that they are relatively low. In studie, 
on isolated papillmy musdes, oxygen consumption was found to 
be a/unction of the tension that is developed and the velocity of 
shortening of the unloaded musde. Shortening against a load 
requires oxygen above and beyond that required for the devel- 
opment of tension. Almost the entire increase in myocardia/ 
oxygen consumption produced by the administration of cat- 
echolamines results from the increased contractile activity pro- 
duced rather than from a direct stimulating e~ect of th; 
catecholamines on myocardial metabolism. Severe valvular 
regurgitation does not increase myocardial consumption sigsdf- 
icantly when myocardial tension is held constant. Congestive 
heart failure is associated with depression of myocardial contrac- 
tility, but this cannot be attributed to any reduction of big/: 
energy phosphate stores in cardiac muscle. A technique for 
reducing myocardial oxygen requirements by stimulating the 
carotid sinus nerves is described and its application to the 
treatment of angina pectoris demonstrated. It is also shown that 
following coronmy occlusion, inte~ventions that increase myo- 
cardial oxygen consumption appear to increase the size of the 
infarction, whereas those that decrease myocardial oxygen con- 
sumption reduce the size of the infarction. 
Originally published in American Journal of Cardiology, April 1971. 
Review 
A decade later, I resumed studies of this subject with new 
collaborators--John Ross, Edmund Sonnenblick, James 
Covell, Neal Coleman, Tom Graham and others. In the 
interim, principles of skeletal muscle mechanics had been 
adapted to the heart. A second set of experiments was 
carried out using a new canine preparation. With the dog on 
total cardiopulmonary bypass, a balloon was placed into the 
left ventricle so that it contracted isometrically; myocardial 
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Table 1. Determinants ofMyocardial Oxygen Consumption 
1 Tension development 
2. Contractile state 
3. Heart rate 
4 Basal cost 
q. Depolarization 
~. Direct metabolic effect of catecholamines 
7. Activation 
,~ Maintenance ofactive state 
~. Shortening against aload-Fenn effect 
contractility was defined as the maximal velocity of calcu- 
lated contractile lement shortening, the so-called Vmax 
l,q). We demonstrated the importance of myocardial con- 
tractility as the third key determinant ofM~rO2 (9,10) and 
then extended our work to the isolated papillary muscle, 
which allowed more precise measurement of myocardial 
.,hortening (11). From this work and the work of other 
investigators, we defined nine determinants of M~-O2--the 
"big three" (systolic wall tension, contractility and heart rate) 
and six others (Table 1). These experiments were then 
e~tended to dogs with experimentally-produced and quan- 
tified valvular egurgitation (12). 
An understanding of the determinants ofMVO 2 clarified 
a number of previously puzzling clinical observations. For 
example, the reduced levels of systolic wall tension in mitral 
,cgurgitation explained the infrequency of ischemic mani- 
ft'stations in patients with this valvular abnormality. The 
rarity of angina in patients with idiopathic dilated cardio- 
myopathy and severe heart failure---despite he increase in 
k't't ventricular volume and, therefore, in wall tension-- 
c.uld be explained by the diminished myocardial contrac- 
t, lity. A reduction of MVO 2 through slowing of heart rate 
and blockade of the stimulant effects of sympathetic influ- 
ences on myocardial contractility was responsible for the 
anti-anginal actions of the beta-adrenoreceptor blockers 
when they were introduced. The reduction of MVO 2 
through alowering of systolic intraventricular pressure (and 
w,dl tension) explained, in part, the benefit of the recently 
developed technique of intra-aortic balloon counterpulsa- 
t,,,n in some patients with acute myocardial ischemia. 
The work of Suga (13) represents a major development 
s.lce the publication of these two papers in the American 
Jourvml of Cardiology (the forerunner of the Journal of the 
z]merican College of Cardiology). This investigator found that 
the left ventricular pressure-volume area (PVA) (i.e., the 
area subtended by the left ventricular pressure-volume 
curve) correlates even more closely with M~rO2 than do 
other variables. More recently, the PVA has been measured 
in humans from left ventricular pressure-volume loops 
(14,15). The imputed M~rO2 at a PVA of zero is considered 
to be the oxygen cost of excitation-contraction c upling; it 
increases with the administration f beta adrenergic agonists 
and decreases with impaired myocardial contractility (15). 
Perhaps of.greatest importance to me was that these 
studies on MVO 2 led my colleagues and me to attempt to 
limit myocardial infarct size following coronary occlusion. 
As stated in the 1971 paper: 
"... An understanding of the determinants of myocardial 
oxygen consumption is particularly relevant to patients with 
acute myocardial infarction... Since the blood supply to 
(the) ischemic segment of myocardium is markedly reduced, 
its survival may depend on its oxygen eeds. If the oxygen 
requirement of the myocardium is stimulated by factors uch 
as increased tension, or contractility, orboth, the viability of 
the ischemic area may be reduced and the size of the infarct 
enlarged... 
"To test this hypothesis, branches of the left anterior 
descending coronary artery were ligated in the open chest 
dog and epicardial leads were recorded over the anterior 
surface of the left ventricle before and after the occlusion. 
Areas of ischemia, i.e., with elevations ofthe ST segment, 
were observed in the direct distribution of the occluded 
vessel... The augmentation f myocardial oxygen con- 
sumption produced by stimulating myocardial contractility 
with the administrations of positive inotropic agents uch as 
isoproterenol caused further elevation of ST seg- 
ments... Conversely, the administration f a beta adren- 
ergic blocking drug, propranolol, which blocks the stimu- 
lating effects of adrenergic agents on the heart, would be 
expected tolower myocardial oxygen demands, and in these 
studies it was found to reduce the ST-segment elevations 
occurring during coronary occlusion. It was of considerable 
interest that changes in myocardial oxygen consumption pro- 
duced as late as 3 hours after coronary occlusion altered the area 
of ischemic njury. (my current emphasis)... 
"Reduction of myocardial oxygen demands produced by 
slowing the heart rate and counteracting the augmentation 
of sympathetic influences may reduce oxygen demands and 
thereby the size of the infarction." (my current emphasis) 
These observations led to a long string of experiments in
the dog and rat, conducted first with the late Peter Maroko 
and subsequently with James Muller and Robert Kloner, in 
which a variety of interventions--including myocardial 
reperfusion--were shown to be effective in limiting myo- 
cardial damage following coronary occlusion (16). These 
experiments, in turn, led to our efforts in the TIMI 
(Thrombolysis n Myocardial Infarction) trials to improve 
clinical outcome with thrombolytic therapy early in the 
course of myocardial infarction (17). 
In 1955, when we began our work on elucidating the 
determinants ofMVO2, we did not appreciate its potential 
clinical relevance. At that time, our experiments were 
categorized as basic physiologic research, of little if any 
clinical import. Their potential clinical significance became 
clear only after a latent period of about 15 years (55 years if 
we take as the starting point the 1915 experiments ofEvans 
and Matsuoko [2] referred to previously). It is gratifying to 
me that we now live in an era in which there is great 
encouragement for investigators to accelerate "bench to 
bedside" translation. 
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